drugset / Trial / NCT04097405
Phase I Study of D-0120 to Evaluate Safety and PK/PD Study in Healthy Volunteers
RandomizedSequentialTriple-blindOther
Summary
This phase 1 study is a randomized, double-blind, placebo controlled, multiple-dose, dose-escalating study to evaluate the safety, tolerability, PK and PD of D-0120 in healthy volunteers.
Timeline
- Start
- 2019-09-18
- Primary completion
- 2020-03-30
- Completion
- 2020-11-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | D-0120 | Unknown | — | — |
Indications
No indication recorded.